Potent and selective inhibitor of phosphodiesterase (PDE) 4 (IC50
= 12 nM for native PDE4). Competitively inhibits all PDE4 isoenzymes (IC50
values are 4, 9, 9 and 45 nM for PDE4A, PDE4B, PDE4C and PDE4D human recombinant isoforms expressed in yeast).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.
Hughes et al.
CDP840: a novel inhibitor of PDE-4.
Perry et al.
Cell Biochem.Biophys., 1998;29:113
A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.
Cooper et al.